These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22023069)

  • 1. The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin.
    Ding Y; Jia YY; Li F; Liu WX; Lu CT; Zhu YR; Yang J; Ding LK; Yang L; Wen AD
    Br J Clin Pharmacol; 2012 Mar; 73(3):422-7. PubMed ID: 22023069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized crossover study investigating the influence of ranitidine or omeprazole on the pharmacokinetics of cephalexin monohydrate.
    Madaras-Kelly K; Michas P; George M; May MP; Adejare A
    J Clin Pharmacol; 2004 Dec; 44(12):1391-7. PubMed ID: 15545310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of two once-daily parenteral cephalexin formulations in dogs.
    Rebuelto M; Montoya L; Kreil V; Ambros L; Waxman S; Albarellos G; Hallu R
    J Vet Pharmacol Ther; 2005 Oct; 28(5):419-23. PubMed ID: 16207303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
    Davis JL; Salmon JH; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronopharmacological study of cephalexin in dogs.
    Prados AP; Ambros L; Montoya L; Rebuelto M
    Chronobiol Int; 2007; 24(1):161-70. PubMed ID: 17364586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amlodipine on the oral bioavailability of cephalexin and cefuroxime axetil in healthy volunteers.
    Ding Y; Liu W; Jia Y; Lu C; Jin X; Yang J; Zhu Y; Yang L; Song Y; Ding L; Wen A
    J Clin Pharmacol; 2013 Jan; 53(1):82-6. PubMed ID: 23400747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoclopramide modifies oral cephalexin pharmacokinetics in dogs.
    Prados AP; Kreil V; Albarellos G; Waxman S; Rebuelto M
    J Vet Pharmacol Ther; 2007 Apr; 30(2):127-31. PubMed ID: 17348897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of a long-acting formulation of cephalexin after intramuscular administration to cats.
    Albarellos GA; Montoya L; Quaine PC; Landoni MF
    Res Vet Sci; 2011 Aug; 91(1):129-131. PubMed ID: 20800248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.
    Kamberi M; Nakashima H; Ogawa K; Oda N; Nakano S
    Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs.
    Papich MG; Davis JL; Floerchinger AM
    Am J Vet Res; 2010 Dec; 71(12):1484-91. PubMed ID: 21118001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of an injectable cephalexin suspension in beef cattle.
    Waxman Dova S; Albarellos G; Kreil V; Montoya L; Ambros L; Hallu R; Rebuelto M
    Res Vet Sci; 2008 Dec; 85(3):570-4. PubMed ID: 18433809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of intravenous cephalexin in pregnant, lactating, and nonpregnant, nonlactating goats.
    Ambros L; Kreil V; Tarragona L; Monfrinotti A; Hallu R; Rebuelto M
    J Vet Pharmacol Ther; 2011 Aug; 34(4):397-402. PubMed ID: 20950353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of cephalexin from two oral formulations in dogs].
    Ehinger AM; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 2002; 115(1-2):57-61. PubMed ID: 11852685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
    Burkhardt O; Stass H; Thuss U; Borner K; Welte T
    Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption kinetics and bioavailability of cephalexin in the dog after oral and intramuscular administration.
    Carli S; Anfossi P; Villa R; Castellani G; Mengozzi G; Montesissa C
    J Vet Pharmacol Ther; 1999 Oct; 22(5):308-13. PubMed ID: 10597534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections.
    Autmizguine J; Watt KM; Théorêt Y; Kassir N; Laferrière C; Parent S; Tapiéro B; Ovetchkine P
    Pediatr Infect Dis J; 2013 Dec; 32(12):1340-4. PubMed ID: 23811740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers.
    Everts RJ; Gardiner SJ; Zhang M; Begg R; Chambers ST; Turnidge J; Begg EJ
    J Infect; 2021 Aug; 83(2):182-189. PubMed ID: 34081957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
    Barbhaiya RH
    Biopharm Drug Dispos; 1996 May; 17(4):319-30. PubMed ID: 8743403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.